- Advancing Gastroenterology and Hepatology through Creative Integration
- Abstract Submission and Registration are available via APDW 2018 website (www.apdw2018.org)
- d-Day
- D1991
Program Details
- Page path
> Scientific Program > Program Details
- GI
(Upper+Lower+Motility) - Liver
- Pancreas & Biliary
- Surgery &
Multidisciplinary - Live Demonstration &
Hands-on Workshop - Endoscopy
- JGHF/APDWF/Other
- KDDW 2018
(in Korean language)
| PG Course-LV | ||
| Nov. 15 (Thu) 09:00-10:30 |
Recent progress in the management of chronic liver diseases | 103 (1F) |
| Chairperson(s) | Diana Payawal (Manila), Jinmo Yang (Suwon) | |
| 09:00-09:20 | Strategies for HBV cure beyond strong viral suppression | Sang Hoon Ahn (Seoul) |
| 09:20-09:40 | Update of concept and pharmacological therapies in nonalcoholic fatty liver disease | Etsuko Hashimoto (Tokyo) |
| 09:40-10:00 | Recent updates in the management of cirrhosis complication: SBP, ascites and varix bleeding | Ashish Kumar (New Delhi) |
| 10:00-10:20 | Differences in HCC treatment strategies: Eastern vs Western Perspectives | Joong-Won Park (Goyang) |
| 10:20-10:30 | Q&As | |
| Symposium LV-K-01 (Korean) | ||
| Nov. 15 (Thu) |
Changing paradigms in the management of chronic liver disease | 105 (1F) |
| Chairperson(s) | Joon-Yeol Han (Seoul), Han Chu Lee (Seoul) | |
| 11:00-11:20 | Chronic hepatitis B in special situation(during pregnancy and immunospressive therapy) | Sae Hwan Lee (Cheonan) |
| 11:20-11:40 | Chronic hepatitis C in serious cases(renal insufficiency, decompensated cirrhosis and HCC) | Hana Park (Seongnam) |
| 11:40-12:00 | Severe alcoholic hepatitis in alcoholic liver disease | Eileen L. Yoon (Seoul) |
| 12:00-12:20 | Non-alcoholic steatohepatitis; Current and future treatment options | Hwi Young Kim (Seoul) |
| 12:20-12:30 | Q & A | |
| Symposium LV-K-02 (Korean) | ||
| Nov. 15 (Thu) |
General review of rare liver diseases | 105 (1F) |
| Chairperson(s) | Kwan Soo Byun (Seoul), Si-Hyun Bae (Seoul) | |
| 14:00-14:20 | Wilson's disease | Hyun Chin Cho (Jinju) |
| 14:20-14:40 | Autoimmune hepatitis | Yanghyun Baek (Busan) |
| 14:40-15:00 | Primary biliary cholangitis | Hee Yeon Kim (Uljeongbu) |
| 15:00-15:20 | Portal vein thrombosis | Nae-Yun Heo (Busan) |
| 15:20-15:30 | Q & A | |
| Free Paper (LV 1) (English) | ||
| Nov. 15 (Thu) 14:00-15:30 |
KDDW Free Paper (LV 01) | E3+4 (3F) |
| Chairperson(s) | Soonho Um (Seoul), Neung Hwa Park (Ulsan) | |
| 14:00-14:10 | Oral branched chain amino acids in patients with hepatocellular carcinoma for transarterial chemoembolization: A meta-analysis | Elvie Victonette Blanco Razon-Gonzalez (Iloilo) |
| 14:10-14:20 | Histopathological heterogeneity in hepatocellular carcinoma: The molecular link | Manoj Kumar Sahu (Bhubaneswar) |
| 14:20-14:30 | A comparison of risk score models to predict the risk of HCC in chronic hepatitis B patients in Thailand | Thanachote Kamalapirat (Bangkok) |
| 14:30-14:40 | Epidemiological, management and barcelona clinic liver cancer staging status of hepatocellular carcinoma: Experience of a tertiary care center. | Talha Qureshi (Karachi) |
| 14:40-14:50 | Elasticity characterization of malignant and benign liver lesions by shear wave elastography | Anoop K (Trivandrum) |
| Chairperson(s) | Soonho Um (Seoul), Hee Bok Chae (Cheongju) | |
| 14:50-15:00 | Factors associated with virological relapse after stopping entecavir therapy in chronic hepatitis B patients | Chien-Jui Huang (Tainan) |
| 15:00-15:10 | Frequency and clinical response of Sofosbuvir, Daclatasvir and Ribavirin in patients of chronic Hepatitis C undergoing hemodialysis | Ghulam Basit Mahesar (Karachi) |
| 15:10-15:20 | Fibroscan in asymptomatic alcoholics | Tejaswini Dande (Chennai) |
| 15:20-15:30 | Development of a new scoring system (EVMAN scoring sytem) for assessment of Hepatic Encephalopathy (HE) | Jose Mathew (Thiruvananthapuram) |
| Symposium LV-K-03 (Korean) | ||
| Nov. 15 (Thu) |
Management of cormobidity in liver disease | 105 (1F) |
| Chairperson(s) | Byung Ho Kim (Seoul), Joon Hyoek Lee (Seoul) | |
| 16:00-16:20 | Geneal and liver specific management of hypertension | Hae Young Lee (Seoul) |
| 16:20-16:40 | Geneal and liver specific selection of antibotics and vaccine | Yu Bin Seo (Seoul) |
| 16:40-17:00 | Geneal and liver specific management of obesity | Yong-Ho Lee (Seoul) |
| 17:00-17:20 | Geneal and liver specific management of psychiatric disorder | Jung-Seok Choi (Seoul) |
| 17:20-17:30 | Q & A | |
| Free Paper (LV 2) (Korean) | ||
| Nov. 15 (Thu) 16:00-17:30 |
KDDW Free Paper (LV 02) | E3+4 (3F) |
| Chairperson(s) | Chul Ju Han (Seoul), Jeong Ill Suh (Gyeongju) | |
| 16:00-16:10 | Longitudinal assessment of three serum biomarkers to detect very early stage hepatocellular carcinoma | Jonggi Choi (Seoul) |
| 16:10-16:20 | Conventional TACE is superior approach to super-selective TACE for tumor necrosis of HCC - a single center experience | Joonho Jeong (Busan) |
| 16:20-16:30 | Postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma : Incidence and risk factor analysis | Hyun Jin Baek (Cheonan) |
| 16:30-16:40 | Preoperative blood neutrophil counts predicts survival in patients with hepatocellular carcinoma undergoing living donor liver transplantation | Young Mi Hong (Yangsan) |
| 16:40-16:50 | Hepatitis C virus genotype 3 was associated with the development of hepatocellular carcinoma in an Asian population | Sang Soo Lee (Changwon) |
| Chairperson(s) | Won-Choong Choi (Seoul), Il Han Song (Cheonan) | |
| 16:50-17:00 | The risk of hbv reactivation among HBV/HCV co-infected patients treated with direct-acting antiviral agents; a single center experience | Young Joo Park (Busan) |
| 17:00-17:10 | The need for chronic hepatitis C treatment in patients with breast cancer undergoing chemotherapy | Kwang Il Seo (Busan) |
| 17:10-17:20 | Clinical features and outcomes of epstein-barr viral hepatitis; Single center experience | Yongho Jang (Cheonan) |
| 17:20-17:30 | Effects of seasonal and temperature variations on variceal bleeding in Korean children | Sowon Park (Seoul) |
| Symposium LV-01 | ||
| Nov. 16 (Fri) 08:30-10:00 |
Chronic hepatitis B: current medication | 103 (1F) |
| Chairperson(s) | Seung Kew Yoon (Seoul), George Lau (Hong Kong) | |
| 08:30-08:50 | Can we stop the neucleot(s)ide analogue? | George Lau (Hong Kong) |
| 08:50-09:10 | Prevention of new HBV infection: nucleotide analogue in pregnant women and vaccination | Henry LY Chan (Hong Kong) |
| 09:10-09:30 | HBV and HCV coinfection | Jidong Jia (Beijing) |
| 09:30-09:50 | Bepatitis B prophylaxis and occult hepatitis B in immunocompromized patients: to whom and how long | Seng Gee Lim (Singapore) |
| 09:50-10:00 | Q&As | |
| PG Course-LV (Korean) | ||
| Nov. 16 (Fri) 08:30-10:00 |
Concerning points and management during treatment for liver disease | E1+2 (3F) |
| Chairperson(s) | So Young Kwon (Seoul), June Sung Lee (Goyang) | |
| 08:30-08:50 | During antiviral therapy for HBV | Hyun Phil Shin (Seoul) |
| 08:50-09:10 | During antiviral therapy for HCV | In Hee Kim (Jeonju) |
| 09:10-09:30 | During imunosuppressive therapy for Autoimmune liver disease | Eun Ju Cho (Seoul) |
| 09:30-09:50 | During systemic therapy for HCC | Sung-Bum Cho (Gwangju) |
| 09:50-10:00 | Q&As | |
| Symposium LV-02 | ||
| Nov. 16 (Fri) 14:00-15:30 |
Chronic hepatitis B: future treatment for the cure | 103 (1F) |
| Chairperson(s) | Seung Woon Paik (Seoul), Shiv Kumar Sarin (New Delhi) | |
| 14:00-14:20 | Potential therapeutic target in hepatitis B virus life cycle | Jia-Horng Kao (Taipei) |
| 14:20-14:40 | Current strategies to maximize HBsAg loss in patients with CHB | Pietro Lampertico (Milan) |
| 14:40-15:00 | Immunologic modulation for hepatitis B treatment | Antonio Bertoletti (Singapore) |
| 15:00-15:20 | Emerging drugs?& new therapeutic perspectives?for HBV | Henry LY Chan (Hong Kong) |
| 15:20-15:30 | Q&As | |
| Symposium LV-03 | ||
| Nov. 16 (Fri) 16:00-17:30 |
Chronic hepatitis C in DAA era | 103 (1F) |
| Chairperson(s) | Kwan Soo Byun (Seoul), Rakesh Aggarwal (Lucknow) | |
| 16:00-16:20 | HCV screening in general population: is this cost-effective in DAA era? | Rakesh Aggarwal (Lucknow) |
| 16:20-16:40 | Is there difficult to treat population in HCV patients in DAA era? | Naoya Sakamoto (Sapporo) |
| 16:40-17:00 | Increased risk of HCC following DAA: fact or fiction?/Follow up strategy after SVR in chronic hepatitis C | Yasuhiro Asahina (Tokyo) |
| 17:00-17:20 | DAA first versus transplantation first in decompensated cirrhotic HCV patients | Young-Suk Lim (Seoul) |
| 17:20-17:30 | Q&As | |
| Symposium LV-04 | ||
| Nov. 17 (Sat) 17:20-17:30 |
Current advances in non-alcoholic fatty liver disease | 101 (1F) |
| Chairperson(s) | Kwang-Hyub Han (Seoul), Jacob George (Westmead) | |
| 08:30-08:50 | New trends on obesity and NAFLD in Asia | Vincent Wong (Hong Kong) |
| 08:50-09:10 | Interactions between bile acids and nuclear receptors in NAFLD | Etsuko Hashimoto (Tokyo) |
| 09:10-09:30 | Clinical trial design and optimal endpoints for nonalcoholic steatohepatitis | Won Kim (Seoul) |
| 09:30-09:50 | Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease | Jacob George (Westmead) |
| 09:50-10:00 | Q&As | |
| Symposium LV-05 | ||
| Nov. 17 (Sat) 10:30-12:00 |
Recent advances in the management of hepatocellular carcinoma | 101 (1F) |
| Chairperson(s) | Joong-Won Park (Goyang), Jose Decena Sollano (Manila) | |
| 10:30-10:50 | Multidisciplinary approach in HCC treatment: various combination strategies and new emerging MTAs in HCC treatment | Masao Omata (Kofu) |
| 10:50-11:10 | Application of new local ablation therapies in HCC: microwave RFA, cryotherapy, etc | Hyunchul Rhim (Seoul) |
| 11:10-11:30 | Comparision of transarterial approaches in HCC treatment: conventional TACE, DEB-TACE vs TARE | Jin Wook Chung (Seoul) |
| 11:30-11:50 | Immunotherapeutic approaches beyond molecular targeted agents in HCC | Thomas Yau (Hong Kong) |
| 11:50-12:00 | Q&As | |
| Symposium LV-06 | ||
| Nov. 17 (Sat) 14:00-15:30 |
Recent changes in the diagnosis and management of liver cirrhosis complication | 101 (1F) |
| Chairperson(s) | Barjesh Chander Sharma (New Delhi), Soon Koo Baik (Wonju) | |
| 14:00-14:20 | Evolving definition and treatment paradigms of acute-on-chronic liver failure | Shiv Kumar Sarin (New Delhi) |
| 14:20-14:40 | Minimal/overt hepatic encephalopathy: diagnostic tools, who should be treated, and how | Woong Ray Kim (Redwood) |
| 14:40-15:00 | Management of refractory ascites | Ashish Kumar (New Delhi) |
| 15:00-15:20 | Recent advances in the management of variceal bleeding | Yeon Seok Seo (Seoul) |
| 15:20-15:30 | Q&As | |
| Symposium LV-07 | ||
| Nov. 18 (Sun) 13:30-15:00 |
Recent advances in liver diseases | 101 (1F) |
| Chairperson(s) | Osamu Yokosuka (Chiba), Moonseok Choi (Seoul) | |
| 13:30-13:50 | Alcoholic liver disease and fecal transplant | Shiv Kumar Sarin (New Delhi) |
| 13:50-14:10 | Cholestatic liver disease | Jidong Jia (Beijing) |
| 14:10-14:30 | Update in drug induced liver injury | Harshad Devarbhavi (Bangalore) |
| 14:30-14:50 | Recent advances in interventional radiology for liver diseases | Dong Il Gwon (Seoul) |
| 14:50-15:00 | Q&As | |
- Supported by
Member Societies -
-
- President : Dong Ki Lee
- Business License No. 106-82-07189
Copyright© 2008 The Korean Society of Gastroenterlogy. All Rights Reserved.
Room 305, 31 Seolleung-ro 86 gil, Gangnam-gu, Seoul, 06193, Korea- TEL:+82-2-538-0627
- FAX:+82-2-538-0635
- E-MAIL: gastrokorea@kams.or.kr
- Associated Societies
-
- Secretariat
-
- TEL: +82-2-3471-8555
- FAX: +82-521-8683
- E-MAIL: kddw2018@insession.co.kr
